% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Klusa:241156,
author = {D. Klusa and F. Lohaus$^*$ and A. Franken and M. Baumbach
and M. Cojoc and P. Dowling and A. Linge$^*$ and A.
Offermann and S. Löck and D. Hušman and M. Rivandi and B.
Polzer and V. Freytag and T. Lange and H. Neubauer and M.
Kücken and S. Perner and T. Hölscher$^*$ and A. Dubrovska
and M. Krause$^*$ and I. Kurth$^*$ and M. Baumann$^*$ and C.
Peitzsch},
title = {{D}ynamics of {CXCR}4 positive circulating tumor cells in
prostate cancer patients during radiotherapy.},
journal = {International journal of cancer},
volume = {152},
number = {12},
issn = {0020-7136},
address = {Bognor Regis},
publisher = {Wiley-Liss},
reportid = {DKFZ-2023-00264},
pages = {2639-2654},
year = {2023},
note = {2023 Jun 15;152(12):2639-2654},
abstract = {Ablative radiotherapy is a highly efficient treatment
modality for patients with metastatic prostate cancer (PCa).
However, a subset of patients does not respond. Currently,
this subgroup with bad prognosis cannot be identified before
disease progression. We hypothesize that markers indicative
of radioresistance, stemness, and/or bone tropism may have a
prognostic potential to identify patients profiting from the
metastases-directed radiotherapy. Therefore, circulating
tumor cells (CTCs) were analyzed in patients with metastatic
PCa (n=24) during radiotherapy with CellSearch, multi-color
flow cytometry and imaging cytometry. Analysis of
copy-number alteration indicate a polyclonal CTC population
that changes after radiotherapy. CTCs were found in 8 out of
24 patients (33.3 $\%)$ and were associated with a shorter
time to biochemical progression after radiotherapy. Whereas
the total CTC count dropped after radiotherapy, a chemokine
receptor CXCR4-expressing subpopulation representing 28.6
$\%$ of the total CTC population remained stable up to three
months. At once, we observed higher chemokine CCL2 plasma
concentrations and pro-inflammatory monocytes. Additional
functional analyses demonstrated key roles of CXCR4 and CCL2
for cellular radiosensitivity, tumorigenicity and stem-like
potential in vitro and in vivo. Moreover, a high CXCR4 and
CCL2 expression was found in bone metastasis biopsies of PCa
patients. In summary, panCK+ CXCR4+ CTCs may have a
prognostic potential in patients with metastatic PCa treated
with metastasis-directed radiotherapy. This article is
protected by copyright. All rights reserved.},
keywords = {CXCR4 (Other) / bone metastasis (Other) / circulating tumor
cells (Other) / prostate cancer (Other) / radiotherapy
(Other)},
cin = {DD01 / E220},
ddc = {610},
cid = {I:(DE-He78)DD01-20160331 / I:(DE-He78)E220-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36733230},
doi = {10.1002/ijc.34457},
url = {https://inrepo02.dkfz.de/record/241156},
}